Keisuke Okamoto
Overview
Explore the profile of Keisuke Okamoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
281
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hart I, Okamoto K, Teruel B, McMahon B
J Neurosurg Case Lessons
. 2025 Mar;
9(10).
PMID: 40063993
Background: Shunt nephritis, although rare, should be high in the differential diagnoses for patients with gross or microscopic hematuria and a history of a ventriculoatrial/cystoatrial shunt. Observations: The authors present...
2.
Morita K, Wang J, Okamoto K, Iwata T
Regen Ther
. 2025 Jan;
28:333-344.
PMID: 39885872
In modern dentistry, prosthetic approaches such as implants and dentures have been developed as symptomatic solutions for tooth loss. However, the complete regeneration of teeth and periodontal tissue, an ultimate...
3.
Yamagami A, Narumi K, Saito Y, Furugen A, Imai S, Okamoto K, et al.
Oral Dis
. 2025 Jan;
PMID: 39791448
Objectives: To externally validate a clinical prediction model for surgical site infection (SSI) after lower third molar (L3M) surgery and evaluate its clinical usefulness. Methods: We conducted a retrospective cohort...
4.
Yamaguchi A, Saito Y, Okamoto K, Furugen A, Narumi K, Takekuma Y, et al.
In Vivo
. 2024 Oct;
38(6):2886-2896.
PMID: 39477436
Background/aim: Immune-related adverse events (irAEs) occur in various organs, and sometimes multiply following treatment with immune checkpoint inhibitors (ICIs). This study aimed to determine the association between the number of...
5.
Okamoto K, Saito Y, Yamaguchi A, Narumi K, Kobayashi M
Int J Clin Oncol
. 2024 Sep;
29(12):1817-1824.
PMID: 39317811
Background: Cisplatin (CDDP) is an anticancer drug used to treat several types of cancer. CDDP-induced nephrotoxicity (CIN) is a serious adverse effect of CDDP treatment. Although magnesium sulfate (Mg) premedication...
6.
Sato T, Narumi K, Taguchi R, Ishihara K, Satoh H, Mori T, et al.
Biol Pharm Bull
. 2024 Sep;
47(9):1477-1483.
PMID: 39231687
Salmon milt extract (SME) is rich in nucleotides, especially deoxyribonucleoside monophosphates (dNMPs), which has the potential to exert anti-obesity effects. Sodium-dependent glucose transporter 1 (SGLT1) and glucose transporter 2 (GLUT2)...
7.
Ishikawa H, Furugen A, Nishimura A, Umazume T, Ishikawa S, Aoyagi R, et al.
J Pharm Biomed Anal
. 2024 Aug;
251:116432.
PMID: 39180895
Pharmaceutical care is important for mental health during the perinatal period, which is often characterized by insomnia. In recent years, prescriptions of melatonin receptor agonists (MRAs) and dual orexin receptor...
8.
Maruyama H, Sano F, Sakaguchi R, Okamoto K, Miura I
Neuropsychiatr Dis Treat
. 2024 Jul;
20:1453-1463.
PMID: 39072313
Purpose: To evaluate the effect of lurasidone on a new, patient Life Engagement scale in schizophrenia. Patients And Methods: This post-hoc analysis included participants (ages 18 to 74) diagnosed with...
9.
Sakuma T, Mukai Y, Yamaguchi A, Suganuma Y, Okamoto K, Furugen A, et al.
Biol Pharm Bull
. 2024 Apr;
47(4):764-770.
PMID: 38569835
L-Lactate transport via monocarboxylate transporters (MCTs) in the central nervous system, represented by the astrocyte-neuron lactate shuttle (ANLS), is crucial for the maintenance of brain functions, including memory formation. Previously,...
10.
Okamoto K, Fukushima H, Kawaguchi M, Tsuruya K
Am J Kidney Dis
. 2024 Mar;
84(2):145-153.e1.
PMID: 38490319
Rationale & Objective: Continuous kidney replacement therapy (CKRT) is preferred when available for hemodynamically unstable acute kidney injury (AKI) patients in the intensive care unit (ICU). The Kidney Disease: Improving...